91 related articles for article (PubMed ID: 14612152)
1. What can be learned from studies of multisubstrate mechanisms of neuronal dopamine transport?
Schenk JO; George SE; Schumacher PD
Eur J Pharmacol; 2003 Oct; 479(1-3):223-8. PubMed ID: 14612152
[TBL] [Abstract][Full Text] [Related]
2. The functioning neuronal transporter for dopamine: kinetic mechanisms and effects of amphetamines, cocaine and methylphenidate.
Schenk JO
Prog Drug Res; 2002; 59():111-31. PubMed ID: 12458965
[TBL] [Abstract][Full Text] [Related]
3. A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine.
Povlock SL; Schenk JO
J Neurochem; 1997 Sep; 69(3):1093-105. PubMed ID: 9282932
[TBL] [Abstract][Full Text] [Related]
4. Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter.
Bonnet JJ
Eur J Pharmacol; 2003 Oct; 479(1-3):199-212. PubMed ID: 14612150
[TBL] [Abstract][Full Text] [Related]
5. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine.
Kahlig KM; Galli A
Eur J Pharmacol; 2003 Oct; 479(1-3):153-8. PubMed ID: 14612146
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
7. Unraveling neuronal dopamine transporter mechanisms with rotating disk electrode voltammetry.
Schenk JO; Wright C; Bjorklund N
J Neurosci Methods; 2005 Apr; 143(1):41-7. PubMed ID: 15763135
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology and regulation of the neuronal dopamine transporter.
Reith ME; Xu C; Chen NH
Eur J Pharmacol; 1997 Apr; 324(1):1-10. PubMed ID: 9137907
[TBL] [Abstract][Full Text] [Related]
9. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
Rothman RB; Dersch CM; Carroll FI; Ananthan S
Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
[TBL] [Abstract][Full Text] [Related]
10. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex.
Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP
J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059
[TBL] [Abstract][Full Text] [Related]
11. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
12. L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism.
Volz TJ; Schenk JO
Synapse; 2004 Dec; 54(3):173-82. PubMed ID: 15452864
[TBL] [Abstract][Full Text] [Related]
13. Dynamic regulation of the dopamine transporter.
Mortensen OV; Amara SG
Eur J Pharmacol; 2003 Oct; 479(1-3):159-70. PubMed ID: 14612147
[TBL] [Abstract][Full Text] [Related]
14. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
Chen N; Zhen J; Reith ME
J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
[TBL] [Abstract][Full Text] [Related]
15. Dopamine efflux via wild-type and mutant dopamine transporters: alanine substitution for proline-572 enhances efflux and reduces dependence on extracellular dopamine, sodium and chloride concentrations.
Itokawa M; Lin Z; Uhl GR
Brain Res Mol Brain Res; 2002 Dec; 108(1-2):71-80. PubMed ID: 12480180
[TBL] [Abstract][Full Text] [Related]
16. Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity.
Volz TJ; Kim M; Schenk JO
Synapse; 2004 Jun; 52(4):272-82. PubMed ID: 15103693
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration.
Storch A; Ludolph AC; Schwarz J
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1267-86. PubMed ID: 15480838
[TBL] [Abstract][Full Text] [Related]
18. Interaction between dopamine and its transporter: role of intracellular sodium ions and membrane potential.
Chen N; Reith ME
J Neurochem; 2004 May; 89(3):750-65. PubMed ID: 15086531
[TBL] [Abstract][Full Text] [Related]
19. Cocaine self-administration in dopamine-transporter knockout mice.
Rocha BA; Fumagalli F; Gainetdinov RR; Jones SR; Ator R; Giros B; Miller GW; Caron MG
Nat Neurosci; 1998 Jun; 1(2):132-7. PubMed ID: 10195128
[TBL] [Abstract][Full Text] [Related]
20. Dopamine transporters depolarize neurons by a channel mechanism.
Carvelli L; McDonald PW; Blakely RD; DeFelice LJ
Proc Natl Acad Sci U S A; 2004 Nov; 101(45):16046-51. PubMed ID: 15520385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]